The Biden administration on Tuesday unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off a controversial process that aims to make costly medications more affordable for older Americans.
President Joe Biden’s Inflation Reduction Act, which passed in a party-line vote last year, gave Medicare the power to directly hash out drug prices with manufacturers for the first time in the federal program’s nearly 60-year history. The agreed-upon prices for the first round of drugs are scheduled to go into effect in 2026.
3 of them are diabetes medicine. That is not exclusively an “old person’s disease”
4 others are for heart disease. Again, not exclusively a geriatric issue.
Given the obesity issues that America has in abundance, I would suggest these drugs are well chosen to help a signifigant portion of the population.
deleted by creator